4 chapters across the catalog
White House COVID-19 Response Coordinator Dr. Ashish Jha announces a shift toward a single annual COVID-19 shot for most Americans, similar to the flu vaccine model. He cautions that this strategy depends on the absence of significant "variant curveballs" that could bypass existing protections.
Financial journalist Andrew Ross Sorkin questioned Scott Gottlieb regarding the necessity of a second booster for those over 50. Gottlieb predicted that the term "booster" will be replaced by "annual vaccine," mirroring the seasonal flu shot model. Both Pfizer and Moderna are developing Omicron-specific vaccines, with data expected to be released in May 2022.
Scott Gottlieb, Pfizer Board, Annual Vaccinations
Former FDA Commissioner and current Pfizer board member Scott Gottlieb appeared on CBS to discuss the potential for annual COVID-19 vaccinations. Gottlieb explained that a fourth dose may be necessary for immunocompromised individuals and that the virus will likely "drift" over time, requiring regular updates. The segment criticizes the media for using Gottlieb as an objective expert while he serves on the board of a vaccine manufacturer.
Pfizer and Moderna, Annual Re-vaccination Projections
Pfizer CEO Albert Bourla and the CEO of Moderna both indicated that the world is moving toward a scenario of annual COVID-19 re-vaccinations. While Bourla suggested life could return to "normal" within a year, he emphasized that vaccinations would remain a permanent fixture of daily life. The discussion also touches on the naming of future variants, including the "Omega" variant.
